Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Research & Development: 2019-2024

Historic Research & Development for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $319.1 million.

  • Relay Therapeutics' Research & Development fell 10.91% to $68.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $274.0 million, marking a year-over-year decrease of 16.58%. This contributed to the annual value of $319.1 million for FY2024, which is 3.31% down from last year.
  • As of FY2024, Relay Therapeutics' Research & Development stood at $319.1 million, which was down 3.31% from $330.0 million recorded in FY2023.
  • Relay Therapeutics' Research & Development's 5-year high stood at $330.0 million during FY2023, with a 5-year trough of $99.9 million in FY2020.
  • In the last 3 years, Relay Therapeutics' Research & Development had a median value of $319.1 million in 2024 and averaged $298.5 million.
  • Per our database at Business Quant, Relay Therapeutics' Research & Development skyrocketed by 72.89% in 2021 and then fell by 3.31% in 2024.
  • Yearly analysis of 5 years shows Relay Therapeutics' Research & Development stood at $99.9 million in 2020, then soared by 72.89% to $172.7 million in 2021, then skyrocketed by 42.69% to $246.4 million in 2022, then soared by 33.96% to $330.0 million in 2023, then declined by 3.31% to $319.1 million in 2024.